{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:14:59Z","timestamp":1789373699763,"version":"build-2803163510"},"publisher-location":"Chichester, UK","reference-count":471,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000284","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:20:09Z","timestamp":1069366809000},"source":"Crossref","is-referenced-by-count":13,"title":["Chlorpromazine versus placebo for schizophrenia"],"prefix":"10.1002","author":[{"given":"B","family":"Thornley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Rathbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CE","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,4,22]]},"reference":[{"key":"10.1002\/14651858.CD000284-BIB1|cit1","first-page":"20","article-title":"Chlorpromazine in the treatment of chronic schizophrenia","volume":"19","author":"Abrams","year":"1958","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB2|cit2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1192\/bjp.105.440.852","article-title":"A controlled trial of ethylcrotonylurea","volume":"105","author":"Baker","year":"1959","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB3|cit3","first-page":"473","article-title":"Comprehensive clinical studies with thiothixene","volume":"36","author":"Ban","year":"1975","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB4|cit4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1176\/ajp.120.2.180","article-title":"Behavioral toxicity associated with benzquinamide (Quantril) therapy in schizophrenic patients","volume":"120","author":"Bishop","year":"1963","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB5|cit5","first-page":"103","article-title":"Does sigma receptor antagonism predict clinical antipsychotic efficacy?","volume":"27","author":"Borison","year":"1991","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/0014-2999(90)93880-Y","article-title":"Sigma receptor antagonism and antipsychotic actions in schizophrenic patients","volume":"183","author":"Borison","year":"1990","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD000284-BIB7|cit7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1600-0447.1990.tb05301.x","article-title":"A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation","volume":"358","author":"Chouinard","year":"1990","journal-title":"Acta Psychiatria Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000284-BIB9|cit8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00592679","article-title":"Chlorpromazine in chronic schizophrenic women. I. Experimental design and effects at maximum point of treatment","volume":"2","author":"Clark","year":"1961","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284-BIB8|cit9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00006842-196305000-00002","article-title":"Chlorpromazine in chronic schizophrenic women: rate of onset and rate of dissipation of drug effects","volume":"25","author":"Clark","year":"1963","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD000284-BIB10|cit10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00005053-196404000-00005","article-title":"Chlorpromazine in chronic schizophrenic women: comparison of differential effects on various psychological modalities during and after treatment","volume":"138","author":"Ray","year":"1964","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB11|cit11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cpt1970116883","article-title":"The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients","volume":"11","author":"Clark","year":"1970","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB12|cit12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/00006842-196711000-00008","article-title":"Chlorpromazine in women with chronic schizophrenia: the effect on cholesterol levels and cholesterol-behavior relationships","volume":"29","author":"Clark","year":"1967","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD000284-BIB13|cit13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00403773","article-title":"Evaluation of trifluperidol in chronic schizophrenia","volume":"12","author":"Clark","year":"1968","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284-BIB14|cit14","first-page":"57","article-title":"Evaluation of butaperazine in chronic schizophrenia","volume":"97","author":"Clark","year":"1968","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB17|cit15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cpt1970116883","article-title":"The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients","volume":"11","author":"Clark","year":"1970","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB15|cit16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/cpt1970115680","article-title":"Molindone in chronic schizophrenia","volume":"11","author":"Clark","year":"1970","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB16|cit17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000468256","article-title":"The EEG effects of chemically and clinically dissimilar antipsychotics: molindone vs. chlorpromazine","volume":"6","author":"Serafetinides","year":"1971","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284-BIB21|cit18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cpt1970116883","article-title":"The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients","volume":"11","author":"Clark","year":"1970","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB19|cit19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archpsyc.1972.01750280047009","article-title":"Chlorpromazine in chronic schizophrenia. The effect of age and hospitalization on behavioral dose-response relationships","volume":"27","author":"Clark","year":"1972","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB18|cit20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF00412672","article-title":"Chlorpromazine in chronic schizophrenia - behavioral dose-response relationships","volume":"18","author":"Clark","year":"1970","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284-BIB20|cit21","first-page":"251","article-title":"EEG dose-response relationships of chlorpromazine in chronic schizophrenia: the effects on the various rhythms and on alpha blocking","volume":"4","author":"Serafetinides","year":"1972","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB22|cit22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/archpsyc.1971.01750170020004","article-title":"Drug treatment in newly admitted schizophrenic patients","volume":"25","author":"Clark","year":"1971","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB23|cit23","first-page":"783","article-title":"Evaluation of loxapine succinate in chronic schizophrenia","volume":"33","author":"Clark","year":"1972","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB24|cit24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000468249","article-title":"The EEG effects of dibenzoxazepines (loxapine succinate) as compared to CPZ: EEG changes as drug side effects","volume":"6","author":"Serafetinides","year":"1971","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284-BIB25|cit25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/j.1552-4604.1977.tb05646.x","article-title":"Evaluation of butaclamol in chronic schizophrenic patients","volume":"17","author":"Clark","year":"1977","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB26|cit26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archpsyc.1968.01740070052008","article-title":"Family interaction patterns, drug treatment, and change in social aggression","volume":"19","author":"Cohen","year":"1968","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000284-BIB27|cit27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00429387","article-title":"Effects of various drugs on flicker fusion frequency. II. Phenothiazine derivatives (with reference to the dependence of the results on the chronological course of experiments","volume":"27","author":"Graupner","year":"1972","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284-BIB28|cit28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archpsyc.1964.01720210028005","article-title":"Phenothiazine treatment in acute schizophrenia","volume":"10","author":"Cole","year":"1964","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB29|cit29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.111.471.120","article-title":"Changes in schizophrenic psychopathology and ward behaviour as a function of phenothiazine treatment","volume":"111","author":"Goldberg","year":"1965","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB30|cit30","first-page":"153","article-title":"Schizophrenic subtypes defined by response to drugs and placebo","volume":"29","author":"Goldberg","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB33|cit31","series-title":"10th ECNP (European College of Neuropsychopharmacology) Congress. Vienna, Austria","article-title":"Zotepine in the treatment of chronic schizophrenia","author":"Cooper"},{"key":"10.1002\/14651858.CD000284-BIB31|cit32","series-title":"XXth Collegium Internationale Neuro-psychopharmacologicum. Melbourne, Australia","article-title":"Zotepine in acute exacerbation of schizophrenia: a comparison versus chlorpromazine and placebo","author":"Cooper","year":"1996"},{"issue":"3","key":"10.1002\/14651858.CD000284-BIB35|cit33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.0902-4441.2000.ap90086.x","article-title":"A placebo controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia","volume":"101","author":"Cooper","year":"2000","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000284-BIB32|cit34","unstructured":"Cooper SJ Tweed J Raniwalla J Welch C A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia Unpublished manuscript 1996"},{"key":"10.1002\/14651858.CD000284-BIB34|cit35","series-title":"10th ECNP (European College of Neuropsychopharmacology) Congress. Vienna, Austria","article-title":"A comparison of zotepine and chlorpromazine on BPRS subscores","author":"Cooper"},{"key":"10.1002\/14651858.CD000284-BIB36|cit36","first-page":"47","article-title":"Schizophrenia treated with and without chlorpromazine","volume":"55","author":"Dean","year":"1958","journal-title":"Rocky Mountain Medical Journal"},{"key":"10.1002\/14651858.CD000284-BIB37|cit37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archpsyc.1964.01720260056007","article-title":"Phenothiazines in prevention of psychiatric hospitalization","volume":"11","author":"Engelhardt","year":"1964","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB39|cit38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.1960.03020200019005","article-title":"Prevention of psychiatric hospitalization with use of psychopharmacological agents","volume":"173","author":"Engelhardt","year":"1960","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1002\/14651858.CD000284-BIB43|cit39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archpsyc.1969.01740150059009","article-title":"Physician bias and the double-blind","volume":"20","author":"Engelhardt","year":"1969","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB40|cit40","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jama.1963.03710110033006","article-title":"Phenothiazines in prevention of psychiatric hospitalization. II. Duration of treatment exposure","volume":"186","author":"Engelhardt","year":"1963","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD000284-BIB38|cit41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1967.01730190100013","article-title":"Phenothiazines in prevention of psychiatric hospitalization. IV. Delay or prevention of hospitalization - a reevaluation","volume":"16","author":"Engelhardt","year":"1967","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB42|cit42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00005053-196701000-00006","article-title":"On the modification of paranoid symptomatology","volume":"144","author":"Freedman","year":"1967","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB41|cit43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00005053-197001000-00008","article-title":"On the modification of paranoid symptomatology. II. Stylistic considerations and the effectiveness of phenothiazines","volume":"150","author":"Freedman","year":"1970","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB44|cit44","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00005053-196806000-00007","article-title":"The hospitalization proneness scale as a predictor of response to phenothiazine treatment","volume":"6","author":"Rosen","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB50|cit45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00005053-196307000-00004","article-title":"The effects of imipramine and chlorpromazine on perceptual analytic ability, perceptual analytic responsivity and memory as revealed in rorschach responses","volume":"137","author":"Belmont","year":"1963","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB45|cit46","first-page":"370","article-title":"Comparative studies of chlorpromazine and imipramine. I. Drug discriminating patterns","volume":"3","author":"Fink","year":"1963","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB46|cit47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/archpsyc.1967.01730190120016","article-title":"Importance of psychiatric diagnosis in prediction of clinical drug effects","volume":"16","author":"Klein","year":"1967","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB47|cit48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00404952","article-title":"Psychiatric diagnosis and a typology of clinical drug effects","volume":"13","author":"Klein","year":"1968","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284-BIB48|cit49","first-page":"159","article-title":"Prediction of drug effect by diagnostic decision tree","volume":"29","author":"Klein","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB49|cit50","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1176\/ajp.122.10.1102","article-title":"Follow up study of formerly hospitalized voluntary psychiatric patients: the first two years","volume":"122","author":"Levenstein","year":"1966","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB51|cit51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1192\/bjp.105.439.349","article-title":"A controlled comparative investigation of the effects of promazine, chlorpromazine, and a placebo in chronic psychosis","volume":"105","author":"Fleming","year":"1959","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB52|cit52","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archneurpsyc.1958.02340060095013","article-title":"Chlorpromazine used with an intensive occupational therapy program. A.M.A","volume":"79","author":"Grygier","year":"1958","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB53|cit53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00005053-195510000-00001","article-title":"A study of chlorpromazine: methodology and results with chronic semi-disturbed schizophrenics","volume":"122","author":"Hall","year":"1955","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB54|cit54","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1176\/ajp.123.2.211","article-title":"Phenothiazine derivatives and morphologic changes in the liver","volume":"123","author":"Hollister","year":"1966","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1176\/ajp.132.10.1023","article-title":"The immediate effects of chlorpromazine in newly admitted schizophrenic patients","volume":"132","author":"Hamill","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB56|cit56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.106.442.40","article-title":"A controlled trial of Thiopropazate Dihydrochloride (Dartalan), Chlorpromazine and occupational therapy in chronic schizophrenics","volume":"106","author":"Hamilton","year":"1960","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB57|cit57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005053-195809000-00002","article-title":"Chlorpromazine in schizophrenic withdrawal and in the withdrawn schizophrenic","volume":"127","author":"Hine","year":"1958","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB61|cit58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archpsyc.1977.01770140061008","article-title":"Prediction of relapse in schizophrenic outpatients treated by drug and sociotherapy","volume":"34","author":"Goldberg","year":"1977","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB58|cit59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archpsyc.1973.01750310038007","article-title":"Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates","volume":"28","author":"Hogarty","year":"1973","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB59|cit60","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archpsyc.1974.01760170011002","article-title":"Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients","volume":"31","author":"Hogarty","year":"1974","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB60|cit61","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1974.01760170005001","article-title":"Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates","volume":"31","author":"Hogarty","year":"1974","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB62|cit62","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/archpsyc.1977.01770150055005","article-title":"Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients","volume":"34","author":"Hogarty","year":"1977","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB63|cit63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004714-198402000-00003","article-title":"Pharmacogenic depression among outpatient schizophrenic patients - a failure to substantiate","volume":"4","author":"Hogarty","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB64|cit64","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/archpsyc.1973.04200040034006","article-title":"Premorbid asocial adjustment and response to phenothiazine treatment among schizophrenic inpatients","volume":"29","author":"Klein","year":"1973","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005053-196107000-00001","article-title":"The comparative effectiveness of six phenothiazine compounds, phenobarbital and inert placebo in the treatment of acutely ill patients: global measures of severity of illness","volume":"133","author":"Kurland","year":"1961","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB66|cit66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00005053-196113210-00010","article-title":"Comparative studies of the phenothiazine tranquilizers: methodological and logistical considerations","volume":"132","author":"Kurland","year":"1961","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1176\/ajp.115.11.1028","article-title":"Pre-admission drug treatment of state psychiatric hospital patients","volume":"115","author":"Kurland","year":"1959","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB68|cit68","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0033-3182(60)72984-0","article-title":"The phenothiazine tranquilizers - their neurological complications and significance","volume":"1","author":"Kurland","year":"1960","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD000284-BIB69|cit69","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1192\/bjp.113.502.950","article-title":"Chlorpromazine and the untreated chronic schizophrenic: a long-term trial","volume":"113","author":"Letemendia","year":"1967","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB70|cit70","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00432759","article-title":"Prophylactic effect of neuroleptics in symptom-free schizophrenics","volume":"77","author":"Nishikawa","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB71|cit71","first-page":"196","article-title":"A Comparison of Trifluopromazine, Chlorpromazine and a Placebo in Twenty-one Chronic Schizophrenic Patients","author":"Payne","year":"1960","journal-title":"Manitoba Medical Review"},{"key":"10.1002\/14651858.CD000284-BIB72|cit72","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1192\/bjp.139.2.105","article-title":"Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo","volume":"139","author":"Peet","year":"1981","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB80|cit73","first-page":"209","article-title":"Tardive dyskinesia in schizophrenic patients treated with psychotropic drugs","volume":"2","author":"Crane","year":"1968","journal-title":"Agressologie"},{"key":"10.1002\/14651858.CD000284-BIB78|cit74","first-page":"19","article-title":"Incidence and significance of chlorpromazine-induced eye changes","volume":"29","author":"Long","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB75|cit75","first-page":"983","article-title":"A 12-year follow-up study of chronic schizophrenics","volume":"33","author":"Gardos","year":"1982","journal-title":"Hospital and Community Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB79|cit76","first-page":"32","article-title":"Agranulocyctosis and phenothiazines","author":"Mandel","year":"1968","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB73|cit77","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archpsyc.1968.01740040098013","article-title":"High dose chlorpromazine therapy in chronic schizophrenia. Report of National Institute of Mental Health - psychopharmacology research branch collaborative study group","volume":"18","author":"Prien","year":"1968","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB74|cit78","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archpsyc.1970.01750050080011","article-title":"Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study","volume":"23","author":"Prien","year":"1970","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB76|cit79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1192\/bjp.115.523.679","article-title":"Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication","volume":"115","author":"Prien","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB77|cit80","first-page":"739","article-title":"Indications for high dose chlorpromazine therapy in chronic schizophrenia","volume":"31","author":"Prien","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB81|cit81","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000468327","article-title":"Are there schizophrenics for whom drugs may be unnecessary or contraindicated?","volume":"13","author":"Rappaport","year":"1978","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284-BIB82|cit82","first-page":"265","article-title":"Acute paranoid schizophrenia (treatment with chlorpromazine, trifluoperazine and placebo)","volume":"27","author":"Reardon","year":"1966","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB83|cit83","first-page":"112","article-title":"Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia","volume":"35","author":"Reschke","year":"1974","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB84|cit84","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1037\/h0023595","article-title":"Effects of chlorpromazine on primary-process thought manifestations","volume":"71","author":"Saretsky","year":"1966","journal-title":"Journal of Abnormal Psychology"},{"key":"10.1002\/14651858.CD000284-BIB85|cit85","first-page":"151","article-title":"A comparison of thioridazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic, hospitalized, schizophrenic patients","volume":"22","author":"Schiele","year":"1961","journal-title":"Journal of Clinical and Experiemental Psychopathology"},{"key":"10.1002\/14651858.CD000284-BIB88|cit86","first-page":"263","article-title":"Psychological effects of single dose antipsychotic medication","volume":"7","author":"Serafetinides","year":"1973","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB86|cit87","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00005053-197201000-00005","article-title":"Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives","volume":"154","author":"Serafetinides","year":"1972","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB89|cit88","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000468000","article-title":"A method of quantifying EEG for psychopharmacological research","volume":"8","author":"Serafetinides","year":"1973","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284-BIB87|cit89","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005053-197211000-00010","article-title":"Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. II. The electroencephalographic effects of chemically unrelated antipsychotics","volume":"155","author":"Serafetinides","year":"1972","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB90|cit90","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jnnp.19.3.232","article-title":"A controlled clinical study of chlorpromazine and reserpine","volume":"19","author":"Shepherd","year":"1956","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB91|cit91","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archpsyc.1965.01720350078010","article-title":"Long-term follow-up study of schizophrenic patients","volume":"12","author":"Simon","year":"1965","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB92|cit92","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1176\/ajp.114.12.1077","article-title":"A controlled study of the short-term differential treatment of schizophrenia","volume":"114","author":"Simon","year":"1958","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB93|cit93","first-page":"153","article-title":"A clinical study of chlorpromazine and chlordiazepoxide","volume":"25","author":"Smith","year":"1961","journal-title":"Connecticut State Medical Journal"},{"key":"10.1002\/14651858.CD000284-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1192\/bjp.106.445.1417","article-title":"Phenothiazine side-effects. Comparison of two major tranquillizers","volume":"106","author":"Somerville","year":"1960","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000284-BIB95|cit95","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.1977.01770180019001","article-title":"Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics","volume":"34","author":"Spohn","year":"1977","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB97|cit96","first-page":"221","article-title":"Comparative study of two drugs and a placebo in chronic schizophrenia","volume":"22","author":"Tetreault","year":"1969","journal-title":"Actualites Pharmacologiques"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB96|cit97","first-page":"74","article-title":"Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients","volume":"30","author":"Tetreault","year":"1969","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(55)90587-0","article-title":"Chlorpromazine in psychiatry","volume":"1","author":"Vaughan","year":"1955","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000284-BIB99|cit99","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1192\/bjp.105.438.199","article-title":"The relative efficacy of \"Vespral\" and chlorpromazine in the treatment of a group of chronic schizophrenic patients","volume":"105","author":"Walsh","year":"1959","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB100|cit100","first-page":"253","article-title":"Therapeutic effect of He-Ne laser irradiation of Point Erman in schizophrenic auditory hallucination - a clinical assessment","volume":"6","author":"Zuoze","year":"1986","journal-title":"Journal of Traditional Chinese Medicine"},{"key":"10.1002\/14651858.CD000284-BIB101|cit101","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1176\/ajp.116.11.973","article-title":"Evaluation of tranquilizing drugs in the management of acute mental disturbance","volume":"117","author":"Abse","year":"1960","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB102|cit102","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00403638","article-title":"An exploration of the autonomic effects of phenothiazines","volume":"7","author":"Acker","year":"1965","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284-BIB103|cit103","first-page":"331","article-title":"The action of a medication and the physician's expectations","volume":"51","author":"Affleck","year":"1966","journal-title":"Nebraska State Medical Journal"},{"key":"10.1002\/14651858.CD000284-BIB104|cit104","first-page":"233","article-title":"Role of ECT phenothiazine combination in schizophrenia","volume":"27","author":"Agarwal","year":"1985","journal-title":"Indian Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB105|cit105","first-page":"1","article-title":"Current status of pharmacotherapy in schizophrenia","volume":"20","author":"Akimoto","year":"1966","journal-title":"Folia Psychiatrica et Neurologica Japonica"},{"key":"10.1002\/14651858.CD000284-BIB106|cit106","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1176\/ajp.122.11.1258","article-title":"Evaluation of treatment with recorded interviews","volume":"122","author":"Alpert","year":"1966","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB107|cit107","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1176\/ajp.135.11.1329","article-title":"Paradoxical reaction to L-dopa in schizophrenic patients","volume":"135","author":"Alpert","year":"1978","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000284-BIB108|cit108","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1097-4679(196410)20:4<462::AID-JCLP2270200415>3.0.CO;2-V","article-title":"The use of adjective check lists with psychotic patients: the problem of pseudo-responses","volume":"20","author":"Alson","year":"1964","journal-title":"Journal of Clinical Psychology"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB109|cit109","first-page":"187","article-title":"Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment","volume":"29","author":"Aman","year":"1985","journal-title":"Journal of Mental Deficiency Research"},{"key":"10.1002\/14651858.CD000284-BIB110|cit110","first-page":"20","article-title":"A standard-controlled clinical study with benzquinamide in the treatment of chronic schizophrenic patients","volume":"13","author":"Amin","year":"1977","journal-title":"Psychopharmacology Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD000284-BIB111|cit111","first-page":"406","article-title":"Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study","volume":"5","author":"Ananth","year":"1972","journal-title":"Internationale Zeitschrift Fur Klinische Pharmakologie Therapie und Toxikologie"},{"key":"10.1002\/14651858.CD000284-BIB112|cit112","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1192\/bjp.128.5.451","article-title":"A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients","volume":"128","author":"Andrews","year":"1976","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB113|cit113","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1192\/bjp.107.447.287","article-title":"A comparison of tetrabenazine and chlorpromazine in chronic schizophrenia","volume":"107","author":"Ashcroft","year":"1961","journal-title":"Journal of Mental Science (British Journal of Psychiatry from 1963)"},{"key":"10.1002\/14651858.CD000284-BIB114|cit114","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004714-198404020-00005","article-title":"Subjective response to antipsychotic drugs: failure to replicate predictions of outcome","volume":"4","author":"Ayers","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB115|cit115","first-page":"116","article-title":"Effects of Largactil in mental syndomes","volume":"71","author":"Azima","year":"1954","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD000284-BIB116|cit116","first-page":"324","article-title":"Evaluation of cognitive effects of ECT: preliminary observations","volume":"23","author":"Bagadia","year":"1981","journal-title":"Indian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB117|cit117","first-page":"119","article-title":"Negative findings with megavitamins in schizophrenic patients - preliminary report","volume":"1","author":"Ban","year":"1977","journal-title":"Communications in Psychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB118|cit118","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/070674377502000621","article-title":"Megavitamin treatment of schizophrenia","volume":"20","author":"Hoffer","year":"1975","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284-BIB119|cit119","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0191-8869(90)90026-N","article-title":"The effect of a small dose of chlorpromazine on a measure of 'cognitive inhibition'","volume":"11","author":"Beech","year":"1990","journal-title":"Personality and Individual Differences"},{"key":"10.1002\/14651858.CD000284-BIB120|cit120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1192\/bjp.106.442.317","article-title":"The effect of chlorpromazine on the incidence of epileptic phenomena during insulin coma therapy: A statistical investigation","volume":"106","author":"Benaim","year":"1960","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD000284-BIB121|cit121","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1176\/ajp.112.10.782","article-title":"Clinical investigation of chlorpromazine and reserpine in private psychiatric practice","volume":"112","author":"Bennett","year":"1956","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB122|cit122","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0022-3956(64)90029-9","article-title":"Effects of chlorpromazine and imipramine on systolic blood pressure in psychiatric patients: Relationships to age, diagnosis and initial blood pressure","volume":"2","author":"Blumberg","year":"1964","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD000284-BIB123|cit123","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/cpt1969103350","article-title":"Chlorpromazine-procyclidine and imipramine: effects on thyroid function in psychiatric patients","volume":"10","author":"Blumberg","year":"1969","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB124|cit124","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2125.1975.tb00468.x","article-title":"Increased platelet aggregation responses to 5-hydroxytryptamine in patients taking chlorpromazine","volume":"2","author":"Boullin","year":"1975","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284-BIB125|cit125","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1176\/ajp.113.6.530","article-title":"The ataractic drugs: the present position of chlorpromazine, frenquel, pacatal, and reserpine in the psychiatric hospital","volume":"113","author":"Bowes","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB126|cit126","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0033-3182(71)71519-9","article-title":"A comparison between chlorpromazine and thiothixene in a Veterans Administration Hospital population","volume":"12","author":"Bressler","year":"1971","journal-title":"Psychosomatics"},{"issue":"9","key":"10.1002\/14651858.CD000284-BIB127|cit127","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1176\/ajp.142.9.1106","article-title":"Effect of methadone plus neuroleptics on treatment-resistant chronic paranoid schizophrenia","volume":"142","author":"Brizer","year":"1985","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB128|cit128","first-page":"625","article-title":"The assessment of thiothixene in chronic schizophrenia. A double-blind controlled trial","volume":"36","author":"Burnett","year":"1975","journal-title":"Diseases of the Nervous System"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB129|cit129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF01878151","article-title":"Treatment of schizophrenic disorder, paranoid type, with intramuscular recombinant alpha-2b interferon","volume":"7","author":"Cabrera Gomez","year":"1994","journal-title":"Biotherapy"},{"key":"10.1002\/14651858.CD000284-BIB130|cit130","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1176\/ajp.120.6.578","article-title":"Phenothiazine excretion in chronic schizophrenics","volume":"120","author":"Caffey","year":"1963","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000284-BIB131|cit131","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0021-9681(64)90075-X","article-title":"Discontinuation or reduction of chemotherapy in chronic schizophrenics","volume":"17","author":"Caffey","year":"1964","journal-title":"Journal of Chronic Diseases"},{"key":"10.1002\/14651858.CD000284-BIB132|cit132","first-page":"1399","article-title":"Practical considerations on treatment with antipsychotic preparations","volume":"75","author":"Caffey","year":"1975","journal-title":"Zhurnal Nevropatologii i Psikhiatrii"},{"key":"10.1002\/14651858.CD000284-BIB133|cit133","first-page":"759","article-title":"Acute responses of schizophrenic children to a sedative and a 'stimulating' neuroleptic: a pharmacologic yardstick","volume":"14","author":"Campbell","year":"1972","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000284-BIB134|cit134","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archpsyc.1970.01750010072013","article-title":"Thiothixene in young disturbed children. A pilot study","volume":"23","author":"Campbell","year":"1970","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB135|cit135","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archpsyc.1969.01740170080012","article-title":"Chlorpromazine and body image. Effects on chronic schizophrenics","volume":"20","author":"Cardone","year":"1969","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB136|cit136","series-title":"Vth World Congress of Psychiatry. Ciudad de Mexico","article-title":"Pharmacologlal treatment of the emotionally unstable character disorder","author":"Carrillo","year":"1971"},{"key":"10.1002\/14651858.CD000284-BIB137|cit137","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.1960.03590080086012","article-title":"Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo","volume":"2","author":"Casey","year":"1960","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB138|cit138","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1176\/ajp.117.11.997","article-title":"Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine","volume":"117","author":"Casey","year":"1961","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB140|cit139","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1973.tb04399.x","article-title":"Clinical and work performance variables in phenothiazine therapy of schizophrenia","volume":"49","author":"Chacon","year":"1973","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD000284-BIB139|cit140","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0010-440X(72)90055-7","article-title":"Work study in the assessment of the effects of phenothiazines in schizophrenia","volume":"13","author":"Chacon","year":"1972","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB141|cit141","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/ajp.118.6.552","article-title":"A comparison of the effectiveness of triluoperazine and chlorpromazine in schizophrenia","volume":"118","author":"Childers","year":"1961","journal-title":"American Journal of Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD000284-BIB142|cit142","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/j.1552-4604.1977.tb04602.x","article-title":"Penfluridol in the maintenance treatment of schizophrenic patients newly discharged from a brief therapy unit","volume":"17","author":"Chouinard","year":"1977","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB143|cit143","first-page":"136","article-title":"Fluspirilene in the treatment of newly admitted schizophrenic patients","volume":"19","author":"Chouinard-G","year":"1983","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB144|cit144","first-page":"138","article-title":"The current status of Clozapine","volume":"19","author":"Claghorn","year":"1983","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB145|cit145","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1001\/jama.1970.03180130071025","article-title":"Ocular pigment deposits: drug-induced false-positives","volume":"214","author":"Clark","year":"1970","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD000284-BIB146|cit146","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cpt1970116883","article-title":"The effect of chlorpromazine on serum cholesterol in chronic schizophrenic patients","volume":"11","author":"Clark","year":"1970","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB147|cit147","first-page":"191","article-title":"A preliminary report on clinical response and blood levels of chlorpromazine and its sulfoxide during chlorpromazine therapy in chronic schizophrenic patients","volume-title":"Pharmacokinetics of psychoactive drugs","author":"Clark","year":"1976"},{"key":"10.1002\/14651858.CD000284-BIB148|cit148","first-page":"28","article-title":"A preliminary report on clinical response and blood levels of chlorpromazine and its sulfoxide during chlorpromazine therapy in chronic schizophrenic patients","volume":"11","author":"Clark","year":"1975","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB149|cit149","first-page":"43","article-title":"Chlorpromazine kinetics and clinical response","volume":"14","author":"Clark","year":"1978","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB150|cit150","first-page":"369","article-title":"Differences in clinical effects of three phenothiazines in \"acute\" schizophrenia","volume":"28","author":"Cole","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB151|cit151","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/070674376200700403","article-title":"Chlorpromazine, trifluoperazine and placebo with long term mental hospital patients","volume":"7","author":"Coons","year":"1962","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284-BIB152|cit152","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1176\/ajp.112.11.898","article-title":"Chlorpromazine: alone and as an adjunct to group psychotherapy in the treatment of psychiatric patients","volume":"4","author":"Cowden","year":"1956","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB153|cit153","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archneur.1970.00480200082009","article-title":"High doses of trifluperazine and tardive dyskinesia","volume":"22","author":"Crane","year":"1970","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD000284-BIB154|cit154","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1176\/ajp.127.10.1407","article-title":"Persistence of neurological symptoms due to neuroleptic drugs","volume":"127","author":"Crane","year":"1971","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB155|cit155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.148.2.120","article-title":"The Northwick Park study of first episodes of schizophrenia. II. A randomised controlled trial of prophylactic neuroleptic treatment","volume":"148","author":"Crow","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB157|cit156","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.148.2.115","article-title":"The Northwick Park study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission","volume":"148","author":"Johnstone","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB156|cit157","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1192\/bjp.148.2.128","article-title":"The Northwick Park study of first episodes of schizophrenia. III. Short-term outcome in trial entrants and trial eligible patients","volume":"148","author":"MacMillan","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB158|cit158","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(72)91943-5","article-title":"Double-blind trial of fluphenazine decanoate","volume":"2","author":"Curry","year":"1972","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000284-BIB159|cit159","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archneurpsyc.1957.02330370075012","article-title":"Effects of \"tranquilizers\" upon pathological activity in psychotic patients: II. Reserpine","volume":"78","author":"Cutler","year":"1957","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB160|cit160","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/bmj.2.5517.793","article-title":"Treatment and outcome of anorexia nervosa","volume":"2","author":"Dally","year":"1966","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD000284-BIB161|cit161","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02245122","article-title":"Effects of chlorpromazine and lorazepam on explicit memory, repetition priming and cognitive skill learning in healthy volunteers","volume":"108","author":"Danion","year":"1992","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000284-BIB162|cit162","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1037\/h0041643","article-title":"Stylus maze performance of chronic schizophrenics taking chlorpromazine","volume":"22","author":"Daston","year":"1958","journal-title":"Journal of Consulting Psychology"},{"key":"10.1002\/14651858.CD000284-BIB163|cit163","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1097-4679(195901)15:1<106::AID-JCLP2270150128>3.0.CO;2-E","article-title":"Effects of two phenothiazine drugs on concentrative attention span of chronic schizophrenics","volume":"15","author":"Daston","year":"1959","journal-title":"Journal of Clinical Psychology"},{"key":"10.1002\/14651858.CD000284-BIB164|cit164","first-page":"1694","article-title":"The use of chlorpromazine in schizophrenia","volume":"69","author":"Davies","year":"1973","journal-title":"Nursing Times"},{"key":"10.1002\/14651858.CD000284-BIB165|cit165","first-page":"925","article-title":"Mefenamic acid and chlorpromazine in porphyria variegata","volume":"41","author":"Dean","year":"1967","journal-title":"South African Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD000284-BIB166|cit166","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1099-1077(200004)15:3<179::AID-HUP156>3.0.CO;2-N","article-title":"Ritanserin as add on medication to neuroleptic therapy for patients with chronic or subchronic schizophrenia","volume":"15","author":"Boer","year":"2000","journal-title":"Human Psychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB167|cit167","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00005053-195511000-00008","article-title":"Studies on Mescaline. VI. Therapeutic Aspects of the Mescaline-Chlorpromazine Combination","volume":"122","author":"Denber","year":"1955","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB168|cit168","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1176\/ajp.112.12.1021","article-title":"Chlorpromazine in the treatment of mental illness. III. The problem of depression","volume":"112","author":"Denber","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB169|cit169","first-page":"76","article-title":"Chlorpromazine-diethazine in the treatment of depression","volume":"18","author":"Denber","year":"1957","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB170|cit170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02431534","article-title":"Possible interactions between zolpidem, a new sleep inducer and chlorpromazine, a phenothiazine neuroleptic","volume":"96","author":"Desager","year":"1988","journal-title":"Psychopharmacology Berlin"},{"key":"10.1002\/14651858.CD000284-BIB171|cit171","first-page":"176","article-title":"A comparison of mesoridazine and chlorpromazine in chronic psychiatric patients","volume":"9","author":"Douglas","year":"1969","journal-title":"Journal of Clinical Pharmacology and The Journal of New Drugs"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB172|cit172","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2466\/pms.1963.17.2.511","article-title":"Effect of phenothiazines on the thinking of acute schizophrenics","volume":"17","author":"Downing","year":"1963","journal-title":"Perceptual and Motor Skills"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB173|cit173","first-page":"193","article-title":"Efficacy of lithium in schizophrenia","volume":"23","author":"Dube","year":"1981","journal-title":"Indian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB174|cit174","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0447.1992.tb01446.x","article-title":"Effects of antipsychotic drugs on memory functions of schizophrenic patients","volume":"85","author":"Eitan","year":"1992","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"487","key":"10.1002\/14651858.CD000284-BIB175|cit175","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1192\/bjp.112.487.633","article-title":"A controlled trial of anti-parkinson drugs in drug-induced parkinsonism","volume":"112","author":"Ekdawi","year":"1966","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB176|cit176","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/bmj.2.4887.560","article-title":"Effect of chlorpromazine on the behaviour of chronically overactive psychotic patients","volume":"2","author":"Elkes","year":"1954","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284-BIB177|cit177","first-page":"25","article-title":"A controlled, blind study of effects of thorazine on psychotic behavior","volume":"20","author":"Feldman","year":"1956","journal-title":"Bulletin of the Menninger Clinic"},{"issue":"15","key":"10.1002\/14651858.CD000284-BIB178|cit178","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1001\/jama.1958.02990150042009","article-title":"Comparative study of chlorpromazine and insulin coma in therapy of psychosis","volume":"166","author":"Fink","year":"1958","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD000284-BIB179|cit179","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00404162","article-title":"Clinical efficacy of chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders","volume":"7","author":"Fink","year":"1965","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284-BIB180|cit180","series-title":"8th Congress of the European College of Neuropsychopharmacology; 1995 Sep 30 - Oct 4; Venice, Italy","article-title":"Broadening treatment perspectives of schizophrenia: a clinical update on seroquel","author":"Fleischhacker","year":"1995"},{"key":"10.1002\/14651858.CD000284-BIB181|cit181","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1192\/bjp.104.436.749","article-title":"Investigation of a new compound, B.W.203, and of Chlorpromazine in the treatment of psychosis","volume":"104","author":"Fleming","year":"1958","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB182|cit182","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1192\/bjp.104.434.201","article-title":"Combined Chlorpromazine and Reserpine in the treatment of chronic psychotics","volume":"104","author":"Foote","year":"1958","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB183|cit183","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0022-3956(67)90016-7","article-title":"The role of personality variables in response to chlorpromazine, dextroamphetamine and placebo","volume":"5","author":"Forrest","year":"1967","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD000284-BIB184|cit184","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1176\/ajp.113.1.22","article-title":"Treatment of hyperkinetic emotionally disturbed children with prolonged administration of chlorpromazine","volume":"113","author":"Freed","year":"1956","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD000284-BIB185|cit185","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1037\/h0021923","article-title":"Communication of body complaints and paranoid symptom change under conditions of phenothiazine treatment","volume":"1","author":"Freedman","year":"1965","journal-title":"Journal of Personality and Social Psychology"},{"key":"10.1002\/14651858.CD000284-BIB186|cit186","first-page":"213","article-title":"Effects of chlorpromazine and reserpine in chronic schizophrenic patients","volume":"17","author":"Freeman","year":"1956","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB187|cit187","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archneurpsyc.1956.02330290044005","article-title":"Effects of chlorpromazine on chronic lobotomized schizophrenic patients. A.M.A","volume":"76","author":"Freeman","year":"1956","journal-title":"Archives of Neurology and Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD000284-BIB188|cit188","first-page":"289","article-title":"A double blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics","volume":"34","author":"Freeman","year":"1973","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB189|cit189","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00005053-196008000-00003","article-title":"The effect of chlorpromazine on the variability of motor task performance in schizophrenics","volume":"131","author":"Friedhoff","year":"1960","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB190|cit190","first-page":"16","article-title":"Controlled study on the value of chlorpromazine in allaying anxiety","volume":"17","author":"Fromm","year":"1956","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB191|cit191","first-page":"1984","article-title":"Evaluation of Chlorpromazine in Comparison with other Methods of treatments of hospitalized psychiatric patients, using the lorr multidimensional scale for rating psychiatric patients","volume":"1","author":"Gaitz","year":"1955","journal-title":"Psychiatric Research Reports"},{"key":"10.1002\/14651858.CD000284-BIB192|cit192","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005053-196808000-00009","article-title":"Predicting response to phenothiazines: the right drug for the right patient","volume":"147","author":"Galbrecht","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB193|cit193","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/070674378803300906","article-title":"Relationship of adverse drug reactions to length of hospital-stay in genetically subgrouped schizophrenics","volume":"33","author":"Galdi","year":"1988","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB194|cit194","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1176\/ajp.119.9.882","article-title":"The relationship between serotonin antagonism and tranquilizing activity","volume":"119","author":"Gallant","year":"1963","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB195|cit195","first-page":"447","article-title":"BL-KR140: a controlled evaluation in chronic schizophrenic patients previously stabilized on chlorpromazine","volume":"9","author":"Gallant","year":"1967","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000284-BIB196|cit196","first-page":"77","article-title":"Objective measurement of psychiatric changes produced by chlorpromazine and reserpine in chronic schizophrenia","volume":"1","author":"Gardner","year":"1955","journal-title":"Psychiatric Research Reports"},{"issue":"12","key":"10.1002\/14651858.CD000284-BIB197|cit197","first-page":"609","article-title":"Trifluoperazine and chlorpromazine in combination and individually","volume":"10","author":"Gardos","year":"1968","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD000284-BIB198|cit198","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1176\/ajp.133.1.32","article-title":"Maintenance antipsychotic therapy: is the cure worse than the disease?","volume":"133","author":"Gardos","year":"1976","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB199|cit199","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00005053-196208000-00008","article-title":"Effects of chlorpromazine on behaviour in emotionally disturbed children","volume":"135","author":"Garfield","year":"1962","journal-title":"Journal of Nervous and Mental Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB200|cit200","first-page":"491","article-title":"Effects of censure and chlorpromazine on visual discrimination behavior of schizophrenic and alcoholic patients","volume":"4","author":"Garmezy","year":"1969","journal-title":"Proceedings of the Annual Convention of the American Psychological Association"},{"key":"10.1002\/14651858.CD000284-BIB201|cit201","first-page":"936","article-title":"Comparative study of trifluperidol and trifluoperazine in the treatment of acute schizophrenia","volume":"96","author":"Gauthier","year":"1967","journal-title":"Union Medicale du Canada"},{"issue":"6","key":"10.1002\/14651858.CD000284-BIB202|cit202","first-page":"333","article-title":"A double blind comparison of AL 1021 and chlorpromazine in hospitalized schizophrenics","volume":"15","author":"Gendron","year":"1973","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000284-BIB204|cit203","first-page":"269","article-title":"A controlled clinical psychiatric study of chlorpromazine","volume":"18","author":"Gibbs","year":"1957","journal-title":"Journal of Clinical and Experimental Psychopathology"},{"key":"10.1002\/14651858.CD000284-BIB203|cit204","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1176\/ajp.113.3.254","article-title":"A controlled clinical psychiatric study of the drug chlorpromazine","volume":"113","author":"Gibbs","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB205|cit205","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2466\/pr0.1957.3.3.561","article-title":"Effects of Thorazine on Wechsler scores of adult catatonic schizophrenics","volume":"3","author":"Gilgash","year":"1957","journal-title":"Psychological Reports"},{"issue":"5","key":"10.1002\/14651858.CD000284-BIB206|cit206","first-page":"S153","article-title":"Schizophrenic subtypes defined by response to drugs and placebo","volume":"29","author":"Goldberg","year":"1968","journal-title":"Diseases of the Nervous System"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB207|cit207","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0447.1970.tb02108.x","article-title":"A comparison of oxypertine and chlorpromazine in chronic schizophrenia","volume":"46","author":"Goldberg","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000284-BIB208|cit208","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/archpsyc.1972.01750220077015","article-title":"Prediction of response to phenothiazines in schizophrenia. A crossvalidation study","volume":"26","author":"Goldberg","year":"1972","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB209|cit209","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jama.1955.02950320004002","article-title":"Treatment of psychotic states with chlorpromazine","volume":"157","author":"Goldman","year":"1955","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD000284-BIB210|cit210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1176\/ajp.115.5.443","article-title":"Termination of chlorpromazine with schizophrenic patients","volume":"115","author":"Good","year":"1958","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB211|cit211","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005053-195808000-00009","article-title":"Influence of chlorpromazine on certain biochemical variables of chronic male schizophrenics","volume":"127","author":"Mefferd","year":"1958","journal-title":"Journal of Nervous and Mental Diseases"},{"issue":"778","key":"10.1002\/14651858.CD000284-BIB212|cit212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/bmj.4.5778.25","article-title":"Persistent phenothiazine dyskinesia treated with tetrabenazine","volume":"4","author":"Godwin-Austen","year":"1971","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284-BIB213|cit213","series-title":"Scientific Papers of the 114th Annual Meeting of the American Psychiatric Association","first-page":"104","article-title":"Clinical Research - Vesperin-Chlorpromazine Therapy","author":"Goyne","year":"1958"},{"issue":"4","key":"10.1002\/14651858.CD000284-BIB214|cit214","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00429387","article-title":"Effects of various drugs on flicker fusion frequency. II. Phenothiazine derivatives (with reference to the dependence of the results on the chronological course of experiments","volume":"27","author":"Graupner","year":"1972","journal-title":"Psychopharmacologia"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB215|cit215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002130050111","article-title":"A comparison of the sedative and amnestic effects of chlorpromazine and lorazepam","volume":"128","author":"Green","year":"1996","journal-title":"Psychopharmacology"},{"issue":"1,2","key":"10.1002\/14651858.CD000284-BIB216|cit216","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-9964(97)88594-5","article-title":"Antisaccade and no-saccade distractibilty with chlorpromazine and lorazepam","volume":"29","author":"Green","year":"1998","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000284-BIB217|cit217","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1176\/ajp.123.2.221","article-title":"Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients","volume":"123","author":"Greenberg","year":"1966","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB218|cit218","first-page":"301","article-title":"Human drug self-administration: double-blind comparison of pentobarbital, diazepam, chlorpromazine and placebo","volume":"210","author":"Griffiths","year":"1979","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB219|cit219","first-page":"22","article-title":"The incidence of treatment emergent symptoms under chlorpromazine and placebo conditions","volume":"14","author":"Guy","year":"1978","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB220|cit220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/14640747808400657","article-title":"Laterality, attention and rate effects in the auditory temporal discrimination of chronic schizophrenics - the effect of treatment with chlorpromazine","volume":"30","author":"Hammond","year":"1978","journal-title":"Quarterly Journal of Experimental Psychology"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB221|cit221","first-page":"107","article-title":"Plasma prolactin in schizophrenia subjects treated with seroquel (TM) (ICI 204,636)","volume":"32","author":"Hamner","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB222|cit222","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archpsyc.1960.01710060089013","article-title":"Denial of illness in schizophrenic outpatients: effects of psychopharmacological treatment","volume":"3","author":"Hankoff","year":"1960","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB223|cit223","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005053-195807000-00003","article-title":"A Comparative Study of Chlorpromazine and Triflupromazine in the Management of the Chronic Hospitalized Psychotic Patient","volume":"127","author":"Hanlon","year":"1958","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB224|cit224","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005053-196001000-00011","article-title":"The psychiatric physician and the phenothiazine tranquilizers","volume":"130","author":"Hanlon","year":"1960","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB225|cit225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2125.1976.tb03713.x","article-title":"Work performance versus clinical assessment in the evaluation of phenothiazine therapy","volume":"3","author":"Harper","year":"1976","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284-BIB226|cit226","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.2044-8295.1978.tb01656.x","article-title":"Chlorpromazine and serial reaction performance","volume":"69","author":"Hartley","year":"1978","journal-title":"British Journal of Psychology"},{"key":"10.1002\/14651858.CD000284-BIB227|cit227","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF02686641","article-title":"Pharmacological effects on lateralized behavior","volume":"6","author":"Hartley","year":"1987","journal-title":"Current Psychology Research and Reviews"},{"key":"10.1002\/14651858.CD000284-BIB228|cit228","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0031-9384(89)90215-1","article-title":"Lateralization of emotional expression under a neuroleptic drug","volume":"45","author":"Hartley","year":"1989","journal-title":"Physiology and Behavior"},{"key":"10.1002\/14651858.CD000284-BIB229|cit229","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0031-9384(91)90409-H","article-title":"Chlorpromazine and the lateralisation of the perception of emotion","volume":"50","author":"Hartley","year":"1991","journal-title":"Physiology and Behavior"},{"key":"10.1002\/14651858.CD000284-BIB230|cit230","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00423056","article-title":"The effects of long term administration of psychotrophic drugs on human sleep. IV. The effects of chlorpromazine","volume":"33","author":"Hartmann","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284-BIB231|cit231","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/j.1552-4604.1974.tb01368.x","article-title":"A controlled outpatient trial of perphenazine-amitriptyline and chlorpromazine","volume":"14","author":"Haskell","year":"1974","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284-BIB232|cit232","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00005053-195904000-00008","article-title":"The effects of chlorpromazine upon psychomotor and psychiatric behavior of chronic schizophrenic patients","volume":"128","author":"Heilizer","year":"1959","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB233|cit233","first-page":"53","article-title":"Weight changes in relation to the characteristics of patients on chlorpromazine","volume":"20","author":"Planansky","year":"1959","journal-title":"Journal of Clinical and Experimental Psychopathology"},{"key":"10.1002\/14651858.CD000284-BIB234|cit234","first-page":"675","article-title":"A controlled study of placebo, chlordiazepoxide and chlorpromazine with thirty male schizophrenic patients","volume":"28","author":"Hekimian","year":"1967","journal-title":"Diseases of the Nervous System"},{"issue":"9","key":"10.1002\/14651858.CD000284-BIB235|cit235","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00005053-198809000-00009","article-title":"High potency neuroleptics and violence in schizophrenics","volume":"176","author":"Herrera","year":"1988","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB236|cit236","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2007-1014469","article-title":"Predictive value of pharmaco electroencephalography in early human pharmacological evaluations of psychoactive drugs - first example - Savoxepine","volume":"24","author":"Herrmann","year":"1991","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284-BIB237|cit237","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2007-1014471","article-title":"Pharmaco EEG profile of maroxepine - third example to discuss the predictive value of pharmaco electroencephalography in early human pharmacological evaluations of psychoactive drugs","volume":"24","author":"Herrmann","year":"1991","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284-BIB238|cit238","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archpsyc.1991.01810280049007","article-title":"Intermittent versus maintenance medication in schizophrenia. Two-year results","volume":"48","author":"Herz","year":"1991","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB239|cit239","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/070674377502000621","article-title":"Megavitamin treatment of schizophrenia","volume":"20","author":"Hoffer","year":"1975","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284-BIB240|cit240","first-page":"494","article-title":"Drug discontinuation among long term, successfully maintained schizophrenic outpatients","volume":"37","author":"Hogarty","year":"1976","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB241|cit241","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.159.3822.1487","article-title":"Chlorpromazine: direct measurement of differential behavioral effect","volume":"159","author":"Hollis","year":"1968","journal-title":"Science"},{"key":"10.1002\/14651858.CD000284-BIB242|cit242","first-page":"218","article-title":"Chlorpromazine alone and with reserpine","volume":"83","author":"Hollister","year":"1955","journal-title":"California Medicine"},{"key":"10.1002\/14651858.CD000284-BIB243|cit243","first-page":"65","article-title":"Psychiatric use of reserpine and chlorpromazine: results of double-blind studies","volume-title":"Psychopharmacology","author":"Hollister","year":"1956"},{"key":"10.1002\/14651858.CD000284-BIB244|cit244","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00004714-198406000-00003","article-title":"Neuroleptic drug-induced changes in platelet levels","volume":"4","author":"Holt","year":"1984","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB245|cit245","series-title":"9th Congress of the European College of Neuropsychopharmacology; 1996 Sep 21-25; Amsterdam, The Netherlands","article-title":"Reduction of the positive symptoms of schizophrenia by '(ICI 204,636): results from phase II and III clinical trials","author":"Hong","year":"1996"},{"key":"10.1002\/14651858.CD000284-BIB246|cit246","series-title":"9th Congress of the European College of Neuropsychopharmacology; 1996 Sep 21-25; Amsterdam, The Netherlands","article-title":"The atypical profile of '(ICI 204,636) is supported by the lack of sustained elevation of plasma prolactin in schizophrenic patients","author":"Hong","year":"1996"},{"key":"10.1002\/14651858.CD000284-BIB247|cit247","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/bmj.1.4869.1036","article-title":"Action of chlorpromazine and promethazine","volume":"1","author":"Hopkin","year":"1954","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284-BIB248|cit248","first-page":"525","article-title":"Resperpine and chlorpromazine in hyperactive mental defectives","author":"Horenstein","year":"1957","journal-title":"American Journal of Mental Deficiency"},{"key":"10.1002\/14651858.CD000284-BIB249|cit249","first-page":"522","article-title":"Therapeutic effects of different modes of chlorpromazine administration","volume":"27","author":"Hrushka","year":"1966","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB250|cit250","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/0006-2952(67)90314-0","article-title":"The effect of antipyretic analgesics on the metabolism of chlorpromazine in man","volume":"16","author":"Huang","year":"1967","journal-title":"Biochemical Pharmacology"},{"key":"10.1002\/14651858.CD000284-BIB251|cit251","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1192\/bjp.113.501.867","article-title":"An appraisal of the continuing practice of prescribing tranquillizing drugs for long-stay psychiatric patients","volume":"113","author":"Hughes","year":"1967","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB252|cit252","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1192\/bjp.106.443.726","article-title":"Chlorpromazine and Pecazine in chronic schizophrenia","volume":"106","author":"Hurst","year":"1960","journal-title":"Journal of Mental Science (British Journal of Psychiatry from 1963)"},{"key":"10.1002\/14651858.CD000284-BIB253|cit253","series-title":"Xth World Congress of Psychiatry. Madrid, Spain","article-title":"A comparison of the tolerance profile of seroquel with typical neuroleptics and placebo","author":"Hurst"},{"key":"10.1002\/14651858.CD000284-BIB254|cit254","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1176\/ajp.126.4.570","article-title":"The effect of chlorpromazine on the swallowing function in chronic schizophrenic patients","volume":"126","author":"Hussar","year":"1969","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB255|cit255","first-page":"267","article-title":"Differentiation of psychotropic drugs by quantitative EEG analysis","volume":"9","author":"Itil","year":"1968","journal-title":"Agressologie"},{"key":"10.1002\/14651858.CD000284-BIB256|cit256","first-page":"195","article-title":"Quantitative pharmaco-electroencephalography in early evaluation of psychotropic drugs","volume":"25","author":"Itil","year":"1971","journal-title":"Folia Psychiatrica et Neurologica Japonica"},{"issue":"8069","key":"10.1002\/14651858.CD000284-BIB257|cit257","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(78)90193-9","article-title":"Mechanism of the antipsychotic effect in the treatment of acute schizophrenia","volume":"1","author":"Johnstone","year":"1978","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000284-BIB258|cit258","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1192\/bjp.115.524.851","article-title":"Drugs and motor activity in chronic schizophrenia","volume":"115","author":"Jones","year":"1969","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB259|cit259","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1192\/bjp.119.552.545","article-title":"Effects of chlorpromazine and trifluoperazine on the activity of chronic schizophrenics","volume":"119","author":"Jones","year":"1971","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB260|cit260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00427342","article-title":"3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol","volume":"64","author":"Joseph","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB261|cit261","first-page":"45","article-title":"Vitamins B1, B6, and B12 in the adjunctive treatment of schizophrenia - further studies to examine the effect of reduction of chlorpromazine dosage","volume":"11","author":"Joshi","year":"1980","journal-title":"Journal of Orthomolecular Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD000284-BIB262|cit262","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000468574","article-title":"Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs","volume":"17","author":"Kabes","year":"1982","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284-BIB263|cit263","first-page":"109","article-title":"Clinical experimentation with desipramine with statistical control","volume":"1","author":"Kammerer","year":"1968","journal-title":"Annales Medico-psychologiques"},{"key":"10.1002\/14651858.CD000284-BIB264|cit264","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1974.01760130044007","article-title":"Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics","volume":"31","author":"Kaplan","year":"1974","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB265|cit265","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0033-3182(70)71674-5","article-title":"A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics","volume":"11","author":"Keskiner","year":"1970","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD000284-BIB266|cit266","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1176\/ajp.116.11.1023","article-title":"Responses to treatment-refractory chronic schizophrenics to chlorpromazine with concurrent adrenocortical steroid","volume":"116","author":"Kim","year":"1960","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB267|cit267","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cpt1971125825","article-title":"Comparison of thioridazine and chlorpromazine in doctor's choice research design","volume":"12","author":"Kimbell","year":"1971","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB268|cit268","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1176\/ajp.115.11.1026","article-title":"Comparison of proclorperazine and chlorpromazine in hospitalized chronic schizophrenics","volume":"115","author":"King","year":"1959","journal-title":"American Journal of Psychiatry"},{"issue":"380","key":"10.1002\/14651858.CD000284-BIB269|cit269","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0447.1994.tb05833.x","article-title":"Psychomotor impairment and cognitive disturbances induced by neuroleptics","volume":"89","author":"King","year":"1994","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000284-BIB270|cit270","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00325481.1954.11711689","article-title":"Chlorpromazine - a major advance in psychiatric treatment","author":"Kinross-Wright","year":"1954","journal-title":"Postgraduate Medicine"},{"key":"10.1002\/14651858.CD000284-BIB271|cit271","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00005053-197406000-00009","article-title":"Self-administration of medication by psychiatric inpatients","volume":"158","author":"Klein","year":"1974","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB272|cit272","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00005053-196810000-00010","article-title":"The effects of chlorpromazine and methamphetamine on visual signal-from-noise detection","volume":"147","author":"Kopell","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB273|cit273","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1192\/bjp.114.512.833","article-title":"Clopenthixol: a controlled trial in chronic hospitalised schizophrenic patients","volume":"114","author":"Kordas","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB275|cit274","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archneurpsyc.1957.02330330111017","article-title":"Relationship between effects of a number of centrally acting drugs and personality","volume":"77","author":"Kornetsky","year":"1957","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB274|cit275","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/archneurpsyc.1957.02330330104016","article-title":"Comparison of psychological effects of certain centrally acting drugs in man","volume":"77","author":"Kornetsky","year":"1957","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB276|cit276","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archneurpsyc.1957.02330330114018","article-title":"Effects of centrally acting drugs on two tests of brain damage","volume":"77","author":"Primac","year":"1957","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB277|cit277","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1192\/bjp.104.437.1093","article-title":"Psychological effects of centrally acting drugs in man","volume":"104","author":"Kornetsky","year":"1958","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD000284-BIB278|cit278","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005053-195912810-00002","article-title":"The effects of chlorpromazine and secobarbital on the C.P.T","volume":"128","author":"Mirsky","year":"1959","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB279|cit279","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1192\/bjp.105.438.190","article-title":"A comparison of the psychological effects of acute and chronic administration of chlorpromazine and secobarbital (quinalbarbitone) in schizophrenic patients","volume":"105","author":"Kornetsky","year":"1959","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD000284-BIB280|cit280","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/cpt196565587","article-title":"Effects of chronic chlorpromazine administration on systemic arterial pressure in schizophrenic patients: relationship of body position to blood pressure","volume":"6","author":"Korol","year":"1965","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB281|cit281","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archneurpsyc.1955.02330170001001","article-title":"A comparison of chlorpromazine and reserpine in chronic psychosis","volume":"74","author":"Kovitz","year":"1955","journal-title":"Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB282|cit282","first-page":"839","article-title":"A double-blind evaluation of metiapine in hospitalized acute schizophrenics","volume":"18","author":"Kramer","year":"1975","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000284-BIB283|cit283","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-1781(80)90008-6","article-title":"The influence of chlorpromazine and amylobarbitone on the recovery limb of the electrodermal response","volume":"2","author":"Kugler","year":"1980","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD000284-BIB284|cit284","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archpsyc.1971.01750080089015","article-title":"Chlorpromazine and sleep in psychiatric patients","volume":"24","author":"Kupfer","year":"1971","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB285|cit285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/j.1552-4604.1981.tb01730.x","article-title":"Viloxazine and the depressed schizophrenic - methodological issues","volume":"21","author":"Kurland","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284-BIB286|cit286","first-page":"300","article-title":"A double blind study of clomacran","volume":"11","author":"Lampe","year":"1969","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD000284-BIB287|cit287","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00403631","article-title":"The effects of chlorpromazine and secobarbital under two conditions of reinforcement on the performance of chronic schizophrenic subjects","volume":"7","author":"Latz","year":"1965","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284-BIB288|cit288","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-2007-1019598","article-title":"Relationship between plasma-levels of chlorpromazine and effects on EEG and evoked potentials in healthy volunteers","volume":"14","author":"Laurian","year":"1981","journal-title":"Pharmacopsychiatria"},{"key":"10.1002\/14651858.CD000284-BIB290|cit289","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/bmj.4.5885.156","article-title":"Influence of selection of patients on results of clinical trials","volume":"4","author":"Leff","year":"1973","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284-BIB289|cit290","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.3.5775.599","article-title":"Trial of maintenance therapy in schizophrenia","volume":"3","author":"Leff","year":"1971","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB291|cit291","first-page":"55","article-title":"Natural human leukocyte interferon in the treatment of schizophrenia","volume":"5","author":"Leszek","year":"1991","journal-title":"European Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB292|cit292","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1037\/h0045486","article-title":"A comparison of the effects of phenobarbital, promethazine, chlorpromazine, and placebo upon mental hospital patients","volume":"23","author":"Levin","year":"1959","journal-title":"Journal of Consulting Psychology"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB293|cit293","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0920-9964(97)00034-0","article-title":"Immediate effects of chlorpromazine and perphenazine following neuroleptic washout on word association of schizophrenic patients","volume":"26","author":"Levine","year":"1997","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000284-BIB294|cit294","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/00221309.1961.9920469","article-title":"Effects of chlorpromazine and promazine on perseveration","volume":"65","author":"Levita","year":"1961","journal-title":"Journal of General Psychology"},{"key":"10.1002\/14651858.CD000284-BIB295|cit295","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00048677309161478","article-title":"Haloperidol and chlorpromazine - a double-blind cross-over trial and clinical study in children and adolescents","volume":"7","author":"Lewis","year":"1973","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB296|cit296","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00005053-197306000-00009","article-title":"Research design for analyzing drug-environment-behavior interactions","volume":"156","author":"Liberman","year":"1973","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB297|cit297","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1192\/bjp.104.435.334","article-title":"A double-blind controlled comparison of the effects of Chlorpromazine, Barbiturate and a placebo in 142 chronic psychotic in-patients","volume":"4","author":"Little","year":"1958","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB298|cit298","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1192\/bjp.114.512.843","article-title":"Treatment of acute mental disorders with an adrenal steroid","volume":"114","author":"Loranger","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB299|cit299","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archpsyc.1961.01710100061007","article-title":"Meprobamate and chlorpromazine in psychotherapy. Some effects on anxiety and hostility of outpatients","volume":"4","author":"Lorr","year":"1961","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB300|cit300","first-page":"711","article-title":"The Use of Chlorpromazine As An Activating Agent","author":"Lyberi","year":"1956","journal-title":"Electroencephalography and Clinical Neurophysiology"},{"key":"10.1002\/14651858.CD000284-BIB301|cit301","first-page":"164","article-title":"Comparison of diazepam, chlorprothixine and chlorpromazine in chronic schizophrenic patients","volume":"25","author":"Maculans","year":"1964","journal-title":"Diseases of the Nervous System"},{"issue":"4","key":"10.1002\/14651858.CD000284-BIB302|cit302","first-page":"283","article-title":"Double blind controlled study of brahmyadiyoga and tagara in the management of various types of unmada (schizophrenia)","volume":"18","author":"Mahal","year":"1976","journal-title":"Indian Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB303|cit303","first-page":"37","article-title":"Results of treatment of schizophrenic psychoses with neuroleptics combined with subcomatic insulin","volume":"2","author":"Majewski","year":"1968","journal-title":"Psychiatria Polska"},{"key":"10.1002\/14651858.CD000284-BIB304|cit304","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/070674376901400412","article-title":"Integrated EEG variability - drug effects in acute schizophrenics","volume":"14","author":"Marjerrison","year":"1969","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284-BIB305|cit305","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1176\/ajp.128.7.886","article-title":"Perceptual challenge to measure illness and therapy","volume":"128","author":"Marrazzi","year":"1972","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB307|cit306","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/ajp.114.2.173-a","article-title":"Perphenazine - a drug modifying consciousness","volume":"114","author":"Mason-Browne","year":"1957","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB306|cit307","first-page":"300","article-title":"Effect of perphenazine (Trilafon) on modification of crude consciousness","volume":"18","author":"Mason-Browne","year":"1957","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB308|cit308","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1192\/bjp.138.3.271a","article-title":"Phenothiazine withdrawal in schizophrenics in a hostel (letter)","volume":"138","author":"Mathur","year":"1981","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB309|cit309","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00192551","article-title":"Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects","volume":"46","author":"Mattila","year":"1994","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284-BIB310|cit310","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2125.1990.tb05444.x","article-title":"A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers","volume":"30","author":"McClelland","year":"1990","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD000284-BIB311|cit311","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/070674376601100507","article-title":"Abrupt withdrawal of chlorpromazine and thioridazine from schizophrenic in-patients","volume":"11","author":"Melnyk","year":"1966","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284-BIB312|cit312","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1176\/ajp.113.11.988","article-title":"Chlorpromazine and chronic neurotic tension","volume":"113","author":"Merry","year":"1957","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB314|cit313","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/009127006600600203","article-title":"Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment: side effects and clinical laboratory findings","volume":"6","author":"Kurland","year":"1966","journal-title":"Journal of New Drugs"},{"issue":"supplement","key":"10.1002\/14651858.CD000284-BIB313|cit314","first-page":"117","article-title":"Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients","volume":"8","author":"Michaux","year":"1966","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1002\/14651858.CD000284-BIB315|cit315","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1192\/bjp.109.460.428","article-title":"A trial of fluphenazine in schizophrenia","volume":"109","author":"Millar","year":"1963","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB316|cit316","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1192\/bjp.106.444.1105","article-title":"A clinical trial of Largactil (chlorpromazine), Stemeticl (prochlorperazine) and Veractil (methotrimeprazine)","volume":"106","author":"Milne","year":"1960","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB317|cit317","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.2044-8341.1978.tb02456.x","article-title":"Confrontation versus belief modification in persistently deluded patients","volume":"51","author":"Milton","year":"1978","journal-title":"British Journal of Medical Psychology"},{"key":"10.1002\/14651858.CD000284-BIB318|cit318","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1192\/bjp.102.426.151","article-title":"Chlorpromazine in the treatment of the chronic disturbed schizophrenic patient","volume":"102","author":"Mitchell","year":"1956","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB319|cit319","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1097-4679(196010)16:4<440::AID-JCLP2270160434>3.0.CO;2-A","article-title":"Psychological response to chlorpromazine in a group of psychiatric patients","volume":"16","author":"Mitchell","year":"1960","journal-title":"Journal of Clinical Psychology"},{"issue":"12","key":"10.1002\/14651858.CD000284-BIB320|cit320","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0006-3223(98)00270-4","article-title":"Prolactin hyperresponsiveness to D fenfluramine in drug free schizophrenic patients: a placebo controlled study","volume":"45","author":"Monteleone","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB321|cit321","first-page":"254","article-title":"Comparative short-term evaluation of triflupromazine hydrochloride, chlorpromazine hyrochloride, and placebo in acutely disturbed patients","volume":"60","author":"Morgenstern","year":"1960","journal-title":"New York State Journal of medicine"},{"key":"10.1002\/14651858.CD000284-BIB322|cit322","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/ajp.124.11.1585","article-title":"A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia","volume":"124","author":"Morton","year":"1968","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB323|cit323","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1176\/ajp.115.5.449","article-title":"Specific behavioural changes produced by chlorpromazine in chronic schizophrenia","volume":"115","author":"Moss","year":"1958","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB324|cit324","first-page":"367","article-title":"A comparative trial of oxypertine and chlorpromazine in chronic schizophrenia","volume":"11","author":"Neal","year":"1969","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"key":"10.1002\/14651858.CD000284-BIB325|cit325","doi-asserted-by":"crossref","DOI":"10.1097\/00005053-195603000-00008","article-title":"The Use of Chlorpromazine in Psychotherapy","author":"Newbold","year":"1956","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB326|cit326","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00431111","article-title":"A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness","volume":"73","author":"Okuma","year":"1981","journal-title":"Psychopharmacology Berlin"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB327|cit327","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cpt1969102258","article-title":"A comparison of the behavioral effects of periodic administration of chlorpromazine and a \"sustained-release\" form of chlorpromazine","volume":"10","author":"Orzack","year":"1969","journal-title":"Clinical Pharamacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB328|cit328","first-page":"1705","article-title":"Use of psychological methods for studying the particular psychotropic action of various psychopharmacologic drugs","volume":"72","author":"Os'makova","year":"1972","journal-title":"Zhurnal Nevropatologii i Psikhiatrii"},{"key":"10.1002\/14651858.CD000284-BIB329|cit329","series-title":"5th World Congress of Psychiatry; 1971 Nov 28 - Dec 4; Ciudad de Mexico, Mexico","author":"Rojo-Sierra","year":"1971"},{"key":"10.1002\/14651858.CD000284-BIB330|cit330","series-title":"Annual Meeting of the American Psychiatric Association; 2001 May 5-10; LA, USA","article-title":"Risperidone in reducing tardive dyskinesia: a double-blind, placebo-controlled study","author":"Pai","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB331|cit331","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005053-196602000-00006","article-title":"Clinical judgment in the assessment of psychopharmacological effects","volume":"142","author":"Paredes","year":"1966","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB332|cit332","first-page":"929","article-title":"Effects of triiodothyronine and chlorpromazine combination treatment in schizophrenia","volume":"29","author":"Park","year":"1981","journal-title":"Current Therapeutic Research - Clinical and Experimental"},{"key":"10.1002\/14651858.CD000284-BIB333|cit333","volume-title":"Schizophrenics in the community: an experimental study in the prevention of hospitalization","author":"Pasamanick","year":"1967"},{"key":"10.1002\/14651858.CD000284-BIB334|cit334","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF00431103","article-title":"Bilateral skin conductance and the pupillary light dark reflex - manipulation by chlorpromazine, haloperidol, scopolamine, and placebo","volume":"73","author":"Patterson","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB335|cit335","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(80)92135-2","article-title":"Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients [letter]","volume":"2","author":"Peet","year":"1980","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000284-BIB336|cit336","first-page":"42","article-title":"A two-year comparative study of ataraxics in neuropsychiatric patients","volume":"5","author":"Pennington","year":"1957","journal-title":"Journal of the American Geriatric Association"},{"key":"10.1002\/14651858.CD000284-BIB337|cit337","first-page":"518","article-title":"Long-term medication in schizophrenia","volume":"49","author":"Pietzcker","year":"1978","journal-title":"Nervenarzt"},{"key":"10.1002\/14651858.CD000284-BIB339|cit338","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0920-9964(93)90075-T","article-title":"The clinical relevance of an auditory attention task (PAT) in a longitudinal study of chronic schizophrenia, with placebo substitution for chlorpromazine","volume":"10","author":"Pigache","year":"1993","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000284-BIB338|cit339","doi-asserted-by":"crossref","first-page":"28P","DOI":"10.1042\/cs044028Pa","article-title":"Measurement of drug action in schizophrenia","volume":"44","author":"Pigache","year":"1973","journal-title":"Clinical Science"},{"key":"10.1002\/14651858.CD000284-BIB340|cit340","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0920-9964(93)90076-U","article-title":"Effects of placebo, orphenadrine, and rising doses of chlorpromazine, on PAT performance in chronic schizophrenia. A two-year longitudinal study","volume":"10","author":"Pigache","year":"1993","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000284-BIB341|cit341","first-page":"601","article-title":"Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine)","volume":"28","author":"Platz","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB342|cit342","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01564324","article-title":"Chlorpromazine (Thorazine) for mental illness in the presence of pulmonary tuberculosis","volume":"30","author":"Pleasure","year":"1956","journal-title":"Psychiatry Quarterly"},{"key":"10.1002\/14651858.CD000284-BIB343|cit343","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1176\/ajp.112.11.937","article-title":"The effect of chlorpromazine on the return rate of 250 patients released from the Rochester State Hospital","volume":"112","author":"Pollack","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB344|cit344","first-page":"427","article-title":"Combined Effects of Chlorpromazine and Meprobamate in Chronically Disturbed Psychotic Patients","volume":"20","author":"Pollard","year":"1959","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB345|cit345","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/026988119601000210","article-title":"The effect of chlorpromazine and benzhexol on memory and psychomotor function in healthy volunteers","volume":"10","author":"Quigley","year":"1996","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB346|cit346","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1192\/bjp.106.442.160","article-title":"A comparative controlled trial of methotrimeprazine ('veractil') in chronic schizophrenia","volume":"106","author":"Quinn","year":"1960","journal-title":"British Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD000284-BIB347|cit347","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s002280000192","article-title":"Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia","volume":"56","author":"Raaska","year":"2000","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD000284-BIB348|cit348","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0021-9681(68)90007-6","article-title":"The evaluation of chlorpromazine therapy in chronic schizophrenic women. A replicated experiment","volume":"21","author":"Ragland","year":"1968","journal-title":"Journal of Chronic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB349|cit349","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0163-8343(00)00055-4","article-title":"Second generation antipsychotics in the emergency care setting. A prospective naturalistic study","volume":"22","author":"Raja","year":"2000","journal-title":"General Hospital Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB350|cit350","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archpsyc.1967.01730250099014","article-title":"Competing voice messages. Effects of message load and drugs on the ability of acute schizophrenics to attend","volume":"17","author":"Rappaport","year":"1967","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB351|cit351","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00005053-196805000-00005","article-title":"Attention to competing voice messages by nonacute schizophrenic patients. Effects of message load, drugs, dosage levels and patient background","volume":"146","author":"Rappaport","year":"1968","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB352|cit352","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1192\/bjp.104.436.705","article-title":"A controlled study of the prognostic significance of autonomic responses in the chlorpromazine treatment of disturbed psychotic patients","volume":"104","author":"Rathod","year":"1958","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB353|cit353","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/bmj.2.5036.63","article-title":"A trial of five tranquillizing drugs in psychoneurosis","volume":"2","author":"Raymond","year":"1957","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284-BIB355|cit354","first-page":"179","article-title":"The effects of chlorpromazine on fine psychomotor performance with a simultaneous secondary task in schizophrenics","volume":"13","author":"Remr","year":"1971","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD000284-BIB354|cit355","first-page":"253","article-title":"The effects of chlorpromazine on some components of psychomotor performance in schizophrenics","volume":"12","author":"Remr","year":"1970","journal-title":"Activitas Nervosa Superior"},{"issue":"4","key":"10.1002\/14651858.CD000284-BIB356|cit356","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/archpsyc.1978.01770280093010","article-title":"Are prophylactic antiparkinson drugs necessary? A controlled study of procyclidine withdrawal","volume":"35","author":"Rifkin","year":"1978","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB357|cit357","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1176\/ajp.112.9.678","article-title":"Clinical evaluation of azacyclonol, chlorpromazine, and reserpine on a group of chronic psychotic patients","volume":"112","author":"Rinaldi","year":"1956","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB358|cit358","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/cpt1973146978","article-title":"Effects of mode of management on plasma chlorpromazine in psychiatric patients","volume":"14","author":"Rivera Calimlim","year":"1973","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB359|cit359","first-page":"271","article-title":"Prediction of psychiatric hospitalization. II. The Hospitalization Proneness Scale: a cross-validation","volume":"80","author":"Rosen","year":"1972","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"9","key":"10.1002\/14651858.CD000284-BIB360|cit360","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4088\/JCP.v61n0913","article-title":"Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia","volume":"61","author":"Rosenheck","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB361|cit361","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00005053-195512000-00001","article-title":"A comparative study of the effect on anxiety of chlorpromazine, reserpine, phenobarbital, and a placebo","volume":"122","author":"Rosner","year":"1955","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB362|cit362","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1176\/ajp.113.11.979","article-title":"Clinical evaluation of two phenothiazine compounds Promazine and Mepazine","volume":"113","author":"Rudy","year":"1957","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB363|cit363","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1176\/ajp.115.4.364","article-title":"Trifluoperazine in the treatment of psychotic patients","volume":"115","author":"Rudy","year":"1958","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB364|cit364","first-page":"14","article-title":"Chlorpromazine in psychiatric disorders","volume":"2","author":"Sainz","year":"1955","journal-title":"Prescriber"},{"key":"10.1002\/14651858.CD000284-BIB365|cit365","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00402529","article-title":"Effect of minor and major tranquilizers on somatosensory evoked potentials","volume":"24","author":"Saletu","year":"1972","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284-BIB366|cit366","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1192\/bjp.103.433.830","article-title":"Ritalin and Chlorpromazine in chronic schizophrenia: a controlled clinical trial","volume":"103","author":"Salisbury","year":"1957","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB367|cit367","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF01575453","article-title":"Comparison of low and high dosage procedures in chlorpromazine therapy","volume":"33","author":"Schiele","year":"1959","journal-title":"Psychiatric Quarterly"},{"key":"10.1002\/14651858.CD000284-BIB368|cit368","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1192\/bjp.103.430.200","article-title":"Combined treatment with chlorpromazine and reserpine: an attempt at quantitative assessments in chronic schizophrenic patients","volume":"103","author":"Schmidt","year":"1957","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB371|cit369","first-page":"157","article-title":"Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios","volume":"1","author":"Sakalis","year":"1977","journal-title":"Communucations in Psychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB370|cit370","first-page":"30","article-title":"Chlorpromazine metabolism and clinical response in acute schizophrenia - a preliminary report","volume":"11","author":"Schooler","year":"1975","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB369|cit371","first-page":"199","article-title":"Chlorpromazine metabolism and clinical response in acute schizophrenia - a preliminary report","volume-title":"Pharmacokinetics of psychoactive drugs","author":"Schooler","year":"1976"},{"key":"10.1002\/14651858.CD000284-BIB372|cit372","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/bmj.1.4918.882","article-title":"Chlorpromazine in treatment of elderly psychotic women","volume":"1","author":"Seager","year":"1955","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD000284-BIB373|cit373","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000467995","article-title":"Consistency and similarity of drug EEG responses in chronic schizophrenic patients","volume":"8","author":"Serafetinides","year":"1973","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284-BIB374|cit374","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1176\/ajp.134.5.512","article-title":"Platelet monoamine oxidase activity in schizophrenic patients","volume":"134","author":"Becker","year":"1977","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB375|cit375","first-page":"29","article-title":"Blood platelet monoamine oxidase activity in anergic schizophrenics","author":"Shaskan","year":"1975","journal-title":"National Institute of Drug Abuse Research Monograph Services"},{"key":"10.1002\/14651858.CD000284-BIB376|cit376","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/253659b0","article-title":"Platelet monoamine oxidase in schizophrenics","volume":"253","author":"Shaskan","year":"1975","journal-title":"Nature"},{"key":"10.1002\/14651858.CD000284-BIB377|cit377","first-page":"452","article-title":"Comparison of chlorpromazine and reserpine in maintenance drug therapy","volume":"20","author":"Shawver","year":"1959","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB378|cit378","first-page":"12","article-title":"Clozapine: double-blind control trial in the treatment of acute schizophrenia","volume":"14","author":"Shopsin","year":"1978","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB379|cit379","first-page":"77","article-title":"Clozapine: antipsychotic activity in treatment-resistant schizophrenics","volume":"1","author":"Honigfeld","year":"1984","journal-title":"Advances in Therapy"},{"key":"10.1002\/14651858.CD000284-BIB380|cit380","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archpsyc.1979.01780060047005","article-title":"Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients","volume":"36","author":"Shopsin","year":"1979","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD000284-BIB381|cit381","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004850-200015050-00002","article-title":"Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study","volume":"15","author":"Silver","year":"2000","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD000284-BIB382|cit382","series-title":"5th World Congress of Psychiatry. Ciudad de Mexico","first-page":"abstract 1077","article-title":"Old wine in new bottles: decreased hostility in chronic psychotic inpatients treated with diphenylhydantoin (Dilantin)","author":"Simopoulos","year":"1971"},{"key":"10.1002\/14651858.CD000284-BIB383|cit383","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cpt1974156631","article-title":"Bioequivalency of generic and brand-named chlorpromazine","volume":"15","author":"Simpson","year":"1974","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD000284-BIB384|cit384","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archpsyc.1980.01780150095010","article-title":"Effect of antiparkinsonian medication on plasma levels of chlorpromazine","volume":"37","author":"Simpson","year":"1980","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB386|cit385","first-page":"191","article-title":"Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance","volume":"37","author":"Singh","year":"1976","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB385|cit386","first-page":"173","article-title":"Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance","volume":"2","author":"Singh","year":"1974","journal-title":"Journal of the Bronx State Hospital"},{"key":"10.1002\/14651858.CD000284-BIB388|cit387","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00421012","article-title":"A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benzotropine in schizophrenia. Theoretical implications for potency differences among neuroleptics","volume":"43","author":"Singh","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000284-BIB387|cit388","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00005053-197504000-00005","article-title":"Therapeutic reversal with benztropine in schizophrenics: practical and theoretical significance","volume":"160","author":"Singh","year":"1975","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB389|cit389","first-page":"319","article-title":"Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis","volume":"51","author":"Singh","year":"1990","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB390|cit390","first-page":"124","article-title":"Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia","volume":"18","author":"Small","year":"1987","journal-title":"Clinical Electroencephalography"},{"key":"10.1002\/14651858.CD000284-BIB391|cit391","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1176\/ajp.115.3.253","article-title":"A comparison of triflupromazine (Vesprin), chlorpromazine and placebo in 85 chronic patients","volume":"115","author":"Smith","year":"1958","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB392|cit392","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1176\/ajp.117.4.362","article-title":"A comparative controlled study with chlordiazepoxide","volume":"117","author":"Smith","year":"1960","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB393|cit393","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00005053-196704000-00006","article-title":"ECT-chlorpromazine and chlorpromazine compared in the treatment of schizophrenia","volume":"144","author":"Smith","year":"1967","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB394|cit394","first-page":"16","article-title":"Chlorpromazine: a controlled study with highly disturbed patients","volume":"18","author":"Sommerness","year":"1957","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB395|cit395","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1192\/bjp.107.448.514","article-title":"Controlled trial of Prochlorperazine (Stemetil) in schizophrenia","volume":"107","year":"1961","journal-title":"Journal of Mental Science (British Journal of Psychiatry from 1963)"},{"key":"10.1002\/14651858.CD000284-BIB396|cit396","first-page":"526","article-title":"The effect of psychopharmacological drugs and other central nervous system effecting drugs on experimental nystagmus","volume":"36","author":"Soyka","year":"1968","journal-title":"Fortschritte Der Neurologie, Psychiatrie Und Ihrer Grenzgebiete"},{"key":"10.1002\/14651858.CD000284-BIB397|cit397","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00005053-196702000-00004","article-title":"The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients","volume":"144","author":"Spiegel","year":"1967","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB398|cit398","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00005053-197409000-00008","article-title":"The effect of chlorpromazine on visual information processing in normal subjects","volume":"159","author":"Spohn","year":"1974","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD000284-BIB399|cit399","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1176\/ajp.121.12.1147","article-title":"Time-series frequency analysis, and electrogenesis of the EEGs of normals and psychotics before and after drugs","volume":"122","author":"Pfeiffer","year":"1965","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB400|cit400","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archpsyc.1964.01720220018005","article-title":"EEG and behavioural changes in schizophrenia","volume":"10","author":"Sugerman","year":"1964","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD000284-BIB401|cit401","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/030006059702500104","article-title":"Citalopram causes no significant alterations in plasma neuroleptic levels in schizophrenic patients","volume":"25","author":"Syvalahti","year":"1997","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD000284-BIB402|cit402","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1176\/ajp.121.6.597","article-title":"Are tranquilizer combinations more effective than a single tranquilizer?","volume":"121","author":"Talbot","year":"1964","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB403|cit403","first-page":"135","article-title":"Full Coma Insulin therapy, Chlorpromazine and Electoconvulsive Treatment. A control study of 600 Schizophrenic patients","volume":"14","author":"Tassis","year":"1959","journal-title":"Medical journal of Malaya"},{"key":"10.1002\/14651858.CD000284-BIB404|cit404","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00048677509159857","article-title":"Tranquilizers or anti-depressants for chronic schizophrenics: a long-term study","volume":"9","author":"Teja","year":"1975","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB405|cit405","first-page":"81","article-title":"A controlled study of chlorpromazine therapy in chronic psychotic patients","volume":"17","author":"Tenenblatt","year":"1956","journal-title":"Journal of Clinical & Experimental Psychopathology"},{"key":"10.1002\/14651858.CD000284-BIB406|cit406","first-page":"24","volume":"23","author":"Terminska","year":"1989","journal-title":"Psychiatria Polska"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB407|cit407","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/070674376901400212","article-title":"Comparative study of fluphenazine ethanate, fluphenazine bichlorhydrate and placebos in chronic schizophrenics","volume":"14","author":"Tetreault","year":"1969","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000284-BIB408|cit408","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1192\/bjp.102.429.790","article-title":"A research method to assess a new tranquillizing drug","volume":"102","author":"Thorpe","year":"1956","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB409|cit409","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/archneurpsyc.1958.02340040112012","article-title":"Chlorpromazine and Communication Processes","volume":"79","author":"Tourlentes","year":"1958","journal-title":"A.M.A. Archives of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB410|cit410","first-page":"11","article-title":"Maintenance phenothiazines in aftercare of schizophrenic patients","volume":"2","author":"Troshinsky","year":"1962","journal-title":"Pennsylvania Psychiatric Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB411|cit411","first-page":"177","article-title":"Changes in the Electroencephalogram, the Electrodermogram, and the Electromyogram Provoked by Chlorpromazine in Man","volume":"20","author":"Turner","year":"1956","journal-title":"Abstracts of World Medicine"},{"key":"10.1002\/14651858.CD000284-BIB412|cit412","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.2042-7158.1966.tb07825.x","article-title":"A comparison of fluphenazine and chlorpromazine on critical flicker fusion frequency","volume":"18","author":"Turner","year":"1966","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1002\/14651858.CD000284-BIB413|cit413","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1192\/bjp.105.438.260","article-title":"Clinical trial of promazine hydrochloride and acetylpromazine in chronic schizophrenic patients","volume":"105","author":"Urquhart","year":"1959","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB415|cit414","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0010-440X(75)90052-8","article-title":"Biochemical versus psychopathological action profile of neuroleptics. A comparative study of chlorpromazine and oxypertine in acute psychotic disorders","volume":"16","author":"Praag","year":"1975","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB414|cit415","first-page":"81","article-title":"The dopamine hypothesis of schizophrenia. Some direct observations","volume-title":"On the origin of schizophrenic psychoses","author":"Praag","year":"1975"},{"key":"10.1002\/14651858.CD000284-BIB416|cit416","doi-asserted-by":"crossref","unstructured":"Vestre ND An experimental study of the effects of chlorpromazine on association learning in schizophrenic patients Dissertation Abstracts 1961 2374","DOI":"10.1037\/h0041544"},{"key":"10.1002\/14651858.CD000284-BIB417|cit417","first-page":"247","article-title":"Whom do neuroleptic drugs help?","volume-title":"Psychopharmacology, Sexual Disorders and Drug Abuse","author":"Vinar","year":"1973"},{"key":"10.1002\/14651858.CD000284-BIB418|cit418","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-1781(83)90071-9","article-title":"Short-lived effect of (des-tyr)-gamma-endorphin in schizophrenia","volume":"10","author":"Volavka","year":"1983","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD000284-BIB419|cit419","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0447.1996.tb10653.x","article-title":"Electrocardiographic changes in patients receiving neuroleptic medication","volume":"93","author":"Warner","year":"1996","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000284-BIB420|cit420","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1192\/bjp.114.506.111","article-title":"The use of pericyazine and chlorpromazine with disturbed mentally subnormal patients","volume":"114","author":"Weir","year":"1968","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB421|cit421","first-page":"113","volume":"14","author":"Welbel","year":"1980","journal-title":"Psychiatria Polska"},{"key":"10.1002\/14651858.CD000284-BIB422|cit422","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1037\/h0049027","article-title":"The effects of chlorpromazine on learning in chronic psychotics","volume":"22","author":"Whitehead","year":"1958","journal-title":"Journal of Consulting Psychology"},{"key":"10.1002\/14651858.CD000284-BIB423|cit423","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00005053-196213530-00005","article-title":"Some Psychophysiological Effects of Chlorpromazine on Emotionally Disturbed Children","volume":"135","author":"Wilcott","year":"1962","journal-title":"Journal of Nervous and Mental Diseases"},{"key":"10.1002\/14651858.CD000284-BIB424|cit424","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1192\/bjp.107.446.90","article-title":"A double-blind trial to investigate the effects of thorazine (largactil, chlorpromazine), compazine (stemetil, prochlorperazine) and stelazine (trifluoperazine) in paranoid schizophrenia","volume":"107","author":"Wilson","year":"1961","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB425|cit425","doi-asserted-by":"crossref","DOI":"10.1176\/ajp.113.11.961","article-title":"An Appraisal of Chlorpromazine. General Principles for Administration of Chlorpromazine, Based on Experience with 1,090 Patients","author":"Winkelman","year":"1957","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB426|cit426","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1037\/h0040207","article-title":"The short-term effects of chlorpromazine on psychiatric patients","volume":"20","author":"Winter","year":"1956","journal-title":"Journal of Consulting Psychology"},{"key":"10.1002\/14651858.CD000284-BIB427|cit427","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0447.1977.tb00229.x","article-title":"Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients","volume":"56","author":"Wode-Helgodt","year":"1977","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000284-BIB428|cit428","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1176\/ajp.116.5.461","article-title":"A long term evaluation of chlorpromazine in six chronic schizophrenic patients","volume":"116","author":"Wold","year":"1959","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD000284-BIB429|cit429","first-page":"487","article-title":"Triiodothyronine and phenothiazines in schizophrenia","volume":"30","author":"Wolpert","year":"1969","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD000284-BIB430|cit430","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1017\/S0033291796004345","article-title":"Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data","volume":"27","author":"Wyatt","year":"1997","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD000284-BIB431|cit431","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(77)91427-1","article-title":"Propranolol as an adjunct to the treatment of schizophrenia","volume":"2","author":"Yorkston","year":"1977","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD000284-BIB432|cit432","first-page":"153","article-title":"A study on the relationship between the chlorprmazine plasma levels and clinical response to chlorpromazine administrations in the schizophrenics","volume":"27","author":"Yuan-Guang","year":"1994","journal-title":"Chinese Journal of Neurology and Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB433|cit433","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.1956.02960380027008","article-title":"Use of chlorpromazine and reserpine in the treatment of emotional disorders","volume":"160","author":"Zeller","year":"1956","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD000284-BIB434|cit434","first-page":"809","article-title":"The blood pressure lowering effect of chlorpromazine and methylperon (Buronil)","volume":"136","author":"Magner","year":"1974","journal-title":"Ugeskrift for Laeger"},{"key":"10.1002\/14651858.CD000284-BIB435|cit435","series-title":"5th World Congress of Psychiatry; 1971 Nov 28 - Dec 4; Ciudad de Mexico, Mexico","first-page":"495","author":"Rojo-Sierra","year":"1971"},{"issue":"3","key":"10.1002\/14651858.CD000284-BIB436|cit436","first-page":"176","article-title":"Schizophrenic syndromes improving without neuroleptic drug treatment","volume":"72","author":"Vinar","year":"1976","journal-title":"Ceskoslovenska Psychiatrie"},{"issue":"3","key":"10.1002\/14651858.CD000284-BIB437|cit437","first-page":"351","article-title":"A double-blind controlled study on the usefulness of carpipramine-chlorpromazine combination in the pharmacotherapy of chronic schizophrenic patients","volume":"4","author":"Yagi","year":"1976","journal-title":"Rinsho Hyoka (Clinical Evaluation)"},{"issue":"8","key":"10.1002\/14651858.CD000284-BIB438|cit438","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/archpsyc.55.8.754","article-title":"Randomised controlled trials in Archives of General Psychiatry (1959-1995): a prevalence study","volume":"55","author":"Ahmed","year":"1998","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB439|cit439","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000284-BIB440|cit440","volume-title":"Tardive dyskinesia: a task force report of the American Psychiatric Association","year":"1992"},{"key":"10.1002\/14651858.CD000284-BIB441|cit441","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1002\/14651858.CD000284-BIB442|cit442","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/schbul\/19.3.609","article-title":"Subjective response to neuroleptics in schizophrenia","volume":"19","author":"Awad","year":"1993","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB443|cit443","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1192\/bjp.170.1.2","article-title":"Early interventions in schizophrenia","volume":"170","author":"Birchwood","year":"1997","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB444|cit444","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S003329170002729X","article-title":"Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials","volume":"24","author":"Bollini","year":"1994","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD000284-BIB445|cit445","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1943-278X.1992.tb01040.x","article-title":"Schizophrenia - a high-risk factor for suicide: clues to risk reduction","volume":"22","author":"Caldwell","year":"1992","journal-title":"Suicide and Life-Threatening Behavior"},{"issue":"2","key":"10.1002\/14651858.CD000284-BIB446|cit446","article-title":"The Cochrane Reviewers Handbook 4.1.4 [updated April 2002]","author":"Clarke","year":"2002","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD000284-BIB447|cit447","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4613-4042-3_4","article-title":"Neuroleptics: clinical use in psychiatry","volume-title":"Handbook of Psychopharmacology","author":"Davis","year":"1978"},{"key":"10.1002\/14651858.CD000284-BIB448|cit448","series-title":"CR Congres des Medicins alienistes et neurologistes de France. Luxembourg","first-page":"479","author":"Delay","year":"1952"},{"key":"10.1002\/14651858.CD000284-BIB449|cit449","first-page":"97","article-title":"The third revolution in psychiatry: fluphenazine decanoate","volume-title":"The future of pharmacotherapy: drug delivery systems","author":"Grozier","year":"1973"},{"key":"10.1002\/14651858.CD000284-BIB450|cit450","volume-title":"Early clinical drug evaluation (ECDEU) assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD000284-BIB451|cit451","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02190336","article-title":"Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders","volume":"242","author":"Hambrecht","year":"1992","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1002\/14651858.CD000284-BIB452|cit452","volume-title":"The Minnesota Multiphasic Personality Inventory Manual","author":"Hathaway","year":"1951"},{"key":"10.1002\/14651858.CD000284-BIB453|cit453","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/00048679209072064","article-title":"Symptomatic response to antipsychotics differs between recent onset and recurrent chronic schizophrenic patients","volume":"26","author":"Hill","year":"1992","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB454|cit454","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD000284-BIB455|cit455","first-page":"357","article-title":"Content and methods of studies on the prevention and treatment of mental disorders in selected psychiatric journals","volume":"38","author":"Jenicek","year":"1990","journal-title":"Revue d'Epidemiologie et de Sante Publique"},{"key":"10.1002\/14651858.CD000284-BIB456|cit456","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1192\/bjp.165.6.787","article-title":"Post-mortem antipsychotic drug concentrations and unexplained deaths","volume":"165","author":"Jusic","year":"1994","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB457|cit457","first-page":"533","article-title":"High-dose versus low-dose strategies in the treatment of schizophrenia","volume":"21","author":"Kane","year":"1985","journal-title":"Psychopharmacological Bulletin"},{"key":"10.1002\/14651858.CD000284-BIB458|cit458","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-3223(90)90650-Q","article-title":"Enlargement of cerebral third ventricle in psychotic patients with delayed response to neuroleptics","volume":"27","author":"Kaplan","year":"1990","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB459|cit459","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1192\/bjp.167.2.184","article-title":"Gender and schizophrenia. Results of an epidemiologically-based family study","volume":"167","author":"Kendler","year":"1995","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB460|cit460","first-page":"1329","volume":"59","author":"Laborit","year":"1951","journal-title":"Presse Medicale"},{"key":"10.1002\/14651858.CD000284-BIB461|cit461","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000284-BIB462|cit462","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000468572","article-title":"Psychotropic drug prescription pattern in a developing country (Nigeria). The need for an essential psychotherapeutic drug list","volume":"17","author":"Odejide","year":"1982","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD000284-BIB463|cit463","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD000284-BIB464|cit464","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1600-0447.1990.tb05312.x","article-title":"Antipsychotics in the elderly","volume":"358","author":"Rosen","year":"1990","journal-title":"Acta Psychiatrica Scandinavica Supplement"},{"key":"10.1002\/14651858.CD000284-BIB465|cit465","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1037\/11420-023","article-title":"Ratings of disturbance in various categories of behavior during hospitalization","volume-title":"The Gerain Quadruplets: a study of heredity and environment in schizophrenia","author":"Rosenthal","year":"1963"},{"key":"10.1002\/14651858.CD000284-BIB466|cit466","volume-title":"Modern Psychometrics","author":"Rust","year":"1989"},{"key":"10.1002\/14651858.CD000284-BIB467|cit467","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(95)91508-7","article-title":"Chemical brain anatomy in schizophrenia","volume":"346","author":"Sedvall","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000284-BIB468|cit468","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1176\/ajp.152.5.698","article-title":"Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients","volume":"152","author":"Szymanski","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB469|cit469","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1176\/ajp.153.4.519","article-title":"Course of treatment response in first-episode and chronic schizophrenia","volume":"153","author":"Szymanski","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000284-BIB470|cit470","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/bmj.317.7167.1181","article-title":"Content and quality of 2000 controlled trials in schizophrenia over 50 years","volume":"317","author":"Thornley","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000284-BIB471|cit471","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archpsyc.1989.01810100071013","article-title":"Antipsychotic drug use in the United States, 1976-1985","volume":"46","author":"Wysowski","year":"1989","journal-title":"Archives of General Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:08:04Z","timestamp":1704960484000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000284"}},"subtitle":[],"editor":[{"given":"Ben","family":"Thornley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,4,22]]},"references-count":471,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000284","relation":{},"subject":[],"published":{"date-parts":[[2003,4,22]]}}}